Evidence map›Paper›PMID 38353876›Full record

ReviewCNS drugs2024

Targeting Pannexin-1 Channels: Addressing the 'Gap' in Chronic Pain.

Brendan B McAllister, Sierra Stokes-Heck, Erika K Harding, Nynke J van den Hoogen, Tuan Trang

Abstract readReview
PubMed Publisher
In one paragraph

Review in CNS drugs, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Brendan B McAllisterFaculty of Veterinary Medicine, University of Calgary, Calgary, AB, T2N 4N1, Canada.ORCID http://orcid.org/0000-0003-4135-3040
Sierra Stokes-HeckFaculty of Veterinary Medicine, University of Calgary, Calgary, AB, T2N 4N1, Canada.ORCID http://orcid.org/0009-0005-0472-8212
Erika K HardingFaculty of Veterinary Medicine, University of Calgary, Calgary, AB, T2N 4N1, Canada.ORCID http://orcid.org/0000-0003-3941-3411
Nynke J van den HoogenFaculty of Veterinary Medicine, University of Calgary, Calgary, AB, T2N 4N1, Canada.ORCID http://orcid.org/0000-0002-1731-2903
Tuan TrangFaculty of Veterinary Medicine, University of Calgary, Calgary, AB, T2N 4N1, Canada. trangt@ucalgary.ca.ORCID http://orcid.org/0000-0003-3309-9492

Funding

Natural Sciences and Engineering Research Council of Canada RGPIN-06289-2019
6 · The paper itself

Abstract

Chronic pain complicates many diseases and is notoriously difficult to treat. In search of new therapeutic targets, pannexin-1 (Panx1) channels have sparked intense interest as a key mechanism involved in a variety of chronic pain conditions. Panx1 channels are transmembrane proteins that release ions and small molecules, such as adenosine triphosphate (ATP). They are expressed along important nodes of the pain pathway, modulating activity of diverse cell types implicated in the development and progression of chronic pain caused by injury or pathology. This review highlights advances that have unlocked the core structure and machinery controlling Panx1 function with a focus on understanding and treating chronic pain.

Indexed as

Chronic PainConnexinsHumansConnexins

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.